Ian Kerridge

34

Articles

0

Comments
  • Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
Ethics committees are the very bodies that ensure the safety of clinical trials. Image from shutterstock.com

Abandoning clinical trial safeguards won’t boost local industry

Paul Komesaroff, Monash University; Colin Thomson, University of Wollongong, and Ian Kerridge, University of Sydney

CLINICAL TRIALS – Human clinical trials are an important last hurdle in the development of new drugs and therapies. Today, The Conversation takes a closer look at this vital scientific endeavour with three…
The scandal started with allegations that GlaxoSmithKline had made illegal payments to doctors and government officials. Ian Wilson

China’s pharma scandal and the ethics of the global drug market

Wendy Lipworth, UNSW and Ian Kerridge, University of Sydney

China is in the midst of conducting a series of corruption investigations of pharmaceutical companies that have been operating in the country. It all started with the investigation of officials from pharmaceutical…
It’s in the public interest to establish the degree of consumer groups’ independence and to expect that their relationships with industry are both disclosed and appropriately managed. Neung Stock Enterprise/Shutterstock

Do consumer groups really advocate for the public interest?

Wendy Lipworth, UNSW and Ian Kerridge, University of Sydney

The Guardian recently claimed to have exposed an attempt by a number of pharmaceutical companies to thwart efforts by the European drug regulator (the European Medicines Agency) to have all clinical trial…
Roche has refused to share clinical trial data for Tamiflu, which is used to relieve symptoms and reduce complications of influenza. AAP/Joe Castro

Remove industry bias from clinical trials before it’s too late

Adam Dunn, UNSW ; Ian Kerridge, University of Sydney, and Wendy Lipworth, UNSW

A study published today shows that clinical trials with industry sponsorship report greater benefits and fewer harmful side effects. In the discussion, the authors note that most reviews and guidelines…
A fundamental change in the relationship between industry and medical professionals is needed. flickr/buddawiggi

Have we reached the limit of effectiveness of self‑regulation and codes of ethics?

Ian Kerridge, University of Sydney; Paul Komesaroff, Monash University, and Wendy Lipworth, UNSW

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Conflict of interest management depends on the existence of a critical culture that recognises the issues. Waldo Jaquith

Don’t show me the money: the dangers of non‑financial conflicts

Paul Komesaroff, Monash University; Ian Kerridge, University of Sydney, and Wendy Lipworth, UNSW

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…

Contact Ian for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision
  • Article Feed
  • Joined